Prof Michael Beresford MBChB MRCP(UK) MRCPCH PhD

Brough Chair, Professor of Child Health Women's and Children's Health

Publications

2017

Adalimumab for Uveitis in Juvenile Idiopathic Arthritis. (Journal article)

Ramanan, A. V., Dick, A. D., & Beresford, M. W. (2017). Adalimumab for Uveitis in Juvenile Idiopathic Arthritis.. The New England journal of medicine, 377(8), 789-790. doi:10.1056/nejmc1708646

DOI: 10.1056/nejmc1708646

Adalimumab plus Methotrexate for Uveitis in Juvenile Idiopathic Arthritis (Journal article)

Ramanan, A. V., Dick, A. D., Jones, A. P., McKay, A., Williamson, P. R., Compeyrot-Lacassagne, S., . . . Grp, S. Y. C. A. M. O. R. E. S. (2017). Adalimumab plus Methotrexate for Uveitis in Juvenile Idiopathic Arthritis. NEW ENGLAND JOURNAL OF MEDICINE, 376(17), 1637-1646. doi:10.1056/NEJMoa1614160

DOI: 10.1056/NEJMoa1614160

Autoantibodies in juvenile-onset myositis: Their diagnostic value and associated clinical phenotype in a large UK cohort. (Journal article)

Tansley, S. L., Simou, S., Shaddick, G., Betteridge, Z. E., Almeida, B., Gunawardena, H., . . . McHugh, N. J. (2017). Autoantibodies in juvenile-onset myositis: Their diagnostic value and associated clinical phenotype in a large UK cohort.. Journal of autoimmunity, 84, 55-64. doi:10.1016/j.jaut.2017.06.007

DOI: 10.1016/j.jaut.2017.06.007

Do classic blood biomarkers of JSLE identify active lupus nephritis? Evidence from the UK JSLE Cohort Study (Journal article)

Smith, E. M. D., Jorgensen, A. L., Beresford, M. W., & Grp, U. K. J. S. L. E. S. (2017). Do classic blood biomarkers of JSLE identify active lupus nephritis? Evidence from the UK JSLE Cohort Study. LUPUS, 26(11), 1212-1217. doi:10.1177/0961203317702253

DOI: 10.1177/0961203317702253

European evidence-based recommendations for diagnosis and treatment of childhood-onset systemic lupus erythematosus: the SHARE initiative. (Journal article)

Groot, N., de Graeff, N., Avcin, T., Bader-Meunier, B., Brogan, P., Dolezalova, P., . . . Beresford, M. W. (2017). European evidence-based recommendations for diagnosis and treatment of childhood-onset systemic lupus erythematosus: the SHARE initiative.. Annals of the rheumatic diseases, 76(11), 1788-1796. doi:10.1136/annrheumdis-2016-210960

DOI: 10.1136/annrheumdis-2016-210960

European evidence-based recommendations for the diagnosis and treatment of childhood-onset lupus nephritis: the SHARE initiative. (Journal article)

Groot, N., de Graeff, N., Marks, S. D., Brogan, P., Avcin, T., Bader-Meunier, B., . . . Kamphuis, S. (2017). European evidence-based recommendations for the diagnosis and treatment of childhood-onset lupus nephritis: the SHARE initiative.. Annals of the rheumatic diseases. doi:10.1136/annrheumdis-2017-211898

DOI: 10.1136/annrheumdis-2017-211898

Evaluation of the ACR and SLICC classification criteria in juvenile-onset systemic lupus erythematosus: a longitudinal analysis (Journal article)

Lythgoe, H., Morgan, T., Heaf, E., Lloyd, O., Al-Abadi, E., Armon, K., . . . Grp, U. K. J. S. L. E. S. (2017). Evaluation of the ACR and SLICC classification criteria in juvenile-onset systemic lupus erythematosus: a longitudinal analysis. LUPUS, 26(12), 1285-1290. doi:10.1177/0961203317700484

DOI: 10.1177/0961203317700484

International validation of a urinary biomarker panel for identification of active lupus nephritis in children. (Journal article)

Smith, E. M. D., Jorgensen, A. L., Midgley, A., Oni, L., Goilav, B., Putterman, C., . . . Beresford, M. W. (2017). International validation of a urinary biomarker panel for identification of active lupus nephritis in children. PEDIATRIC NEPHROLOGY, 32(2), 283-295. doi:10.1007/s00467-016-3485-3

DOI: 10.1007/s00467-016-3485-3

Mortality rates are increased in patients with systemic juvenile idiopathic arthritis. (Journal article)

Davies, R., Southwood, T., Kearsley-Fleet, L., Lunt, M., Baildam, E., Beresford, M. W., . . . Grp, B. S. P. A. R. -E. T. N. S. (2017). Mortality rates are increased in patients with systemic juvenile idiopathic arthritis. ARCHIVES OF DISEASE IN CHILDHOOD, 102(2). doi:10.1136/archdischild-2016-311571

DOI: 10.1136/archdischild-2016-311571

Optimising the use of medicines to reduce acute kidney injury in children and babies (Journal article)

Oni, L., Hawcutt, D. B., Turner, M. A., Beresford, M. W., McWilliam, S., Barton, C., . . . Antoine, D. J. (2017). Optimising the use of medicines to reduce acute kidney injury in children and babies. PHARMACOLOGY & THERAPEUTICS, 174, 55-62. doi:10.1016/j.pharmthera.2017.02.018

DOI: 10.1016/j.pharmthera.2017.02.018

Optimization of Antimicrobial Therapy for Gram-positive Bacterial Infections in Children using a Translational Pharmacological Approach (Thesis / Dissertation)

Ramos Martín, V. (2017, April 13). Optimization of Antimicrobial Therapy for Gram-positive Bacterial Infections in Children using a Translational Pharmacological Approach.

PRESCRIBING PATTERNS IN JUVENILE IDIOPATHIC ARTHRITIS: A SURVEY OF CURRENT PRACTICE IN THE UNITED KINGDOM (Conference Paper)

Hawley, D. P., Foster, H. E., Beresford, M. W., Ramanan, A., Rapley, T., & McErlane, F. (2017). PRESCRIBING PATTERNS IN JUVENILE IDIOPATHIC ARTHRITIS: A SURVEY OF CURRENT PRACTICE IN THE UNITED KINGDOM. In RHEUMATOLOGY Vol. 56 (pp. 168-169). Retrieved from http://gateway.webofknowledge.com/

Tools for the Individualized Therapy of Teicoplanin for Neonates and Children (Journal article)

Ramos-Martin, V., Neely, M. N., Padmore, K., Peak, M., Beresford, M. W., Turner, M. A., . . . Hope, W. W. (2017). Tools for the Individualized Therapy of Teicoplanin for Neonates and Children. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 61(10). doi:10.1128/AAC.00707-17

DOI: 10.1128/AAC.00707-17

2016

ACTIVATION OF THE STAT1 PATHWAY BY TYPE 1 AND 2 INTERFERONS AND SUBSEQUENT EFFECT ON NEUTROPHIL APOPTOSIS (Conference Paper)

Irwin, S., Midgley, A., Wright, R. D., Peak, M., & Beresford, M. W. (2016). ACTIVATION OF THE STAT1 PATHWAY BY TYPE 1 AND 2 INTERFERONS AND SUBSEQUENT EFFECT ON NEUTROPHIL APOPTOSIS. In CLINICAL AND EXPERIMENTAL RHEUMATOLOGY Vol. 34 (pp. S58). Retrieved from http://gateway.webofknowledge.com/

ADALIMUMAB IN COMBINATION WITH METHOTREXATE FOR THE TREATMENT OF JUVENILE IDIOPATHIC ARTHRITIS ASSOCIATED UVEITIS: THE SYCAMORE TRIAL (Conference Paper)

Ramanan, A. V., Dick, A. D., Jones, A. P., McKay, A., Williamson, P. R., Compeyrot-Lacassagne, S., . . . Beresford, M. W. (2016). ADALIMUMAB IN COMBINATION WITH METHOTREXATE FOR THE TREATMENT OF JUVENILE IDIOPATHIC ARTHRITIS ASSOCIATED UVEITIS: THE SYCAMORE TRIAL. In ANNALS OF THE RHEUMATIC DISEASES Vol. 75 (pp. 264-265). doi:10.1136/annrheumdis-2016-eular.6053

DOI: 10.1136/annrheumdis-2016-eular.6053

Developing a Lupus Nephritis urinary biomarker panel in children for use in a clinical trial (Thesis / Dissertation)

Smith, E. M. D. (2016, August 15). Developing a Lupus Nephritis urinary biomarker panel in children for use in a clinical trial.

Developing a Lupus Nephritis urinary biomarker panel in children for use in a clinical trial (ABRIDGED VERSION) (Thesis / Dissertation)

Smith, E. M. (2016, August 15). Developing a Lupus Nephritis urinary biomarker panel in children for use in a clinical trial (ABRIDGED VERSION).

Differences in disease phenotype and severity in SLE across age groups (Journal article)

Ambrose, N., Morgan, T. A., Galloway, J., Ionnoau, Y., Beresford, M. W., Isenberg, D. A., & Grp, U. K. J. S. L. E. S. (2016). Differences in disease phenotype and severity in SLE across age groups. LUPUS, 25(14), 1542-1550. doi:10.1177/0961203316644333

DOI: 10.1177/0961203316644333

EVALUATION OF THE ACR AND SLICC CLASSIFICATION CRITERIA IN JUVENILE SYSTEMIC LUPUS ERYTHEMATOSUS: A LONGITUDINAL ANALYSIS (Conference Paper)

Lythgoe, H., Morgan, T., Heaf, E., Lloyd, O., Beresford, M. W., & Grp, U. K. J. S. L. E. S. (2016). EVALUATION OF THE ACR AND SLICC CLASSIFICATION CRITERIA IN JUVENILE SYSTEMIC LUPUS ERYTHEMATOSUS: A LONGITUDINAL ANALYSIS. In ANNALS OF THE RHEUMATIC DISEASES Vol. 75 (pp. 139). doi:10.1136/annrheumdis-2016-eular.3430

DOI: 10.1136/annrheumdis-2016-eular.3430

FACTORS ASSOCIATED WITH CHOICE OF FIRST BIOLOGIC AMONG CHILDREN WITH JUVENILE IDIOPATHIC ARTHRITIS: A COMBINED ANALYSIS FROM TWO UK PAEDIATRIC BIOLOGIC REGISTERS (Journal article)

Kearsley-Fleet, L., Davies, R., Baildam, E., Beresford, M. W., Foster, H. E., Southwood, T. R., . . . Hyrich, K. L. (2015). FACTORS ASSOCIATED WITH CHOICE OF FIRST BIOLOGIC AMONG CHILDREN WITH JUVENILE IDIOPATHIC ARTHRITIS: A COMBINED ANALYSIS FROM TWO UK PAEDIATRIC BIOLOGIC REGISTERS. RHEUMATOLOGY, 54, 156. Retrieved from http://gateway.webofknowledge.com/

Factors associated with choice of biologic among children with Juvenile Idiopathic Arthritis: results from two UK paediatric biologic registers (Journal article)

Kearsley-Fleet, L., Davies, R., Baildam, E., Beresford, M. W., Foster, H. E., Southwood, T. R., . . . Hyrich, K. L. (2016). Factors associated with choice of biologic among children with Juvenile Idiopathic Arthritis: results from two UK paediatric biologic registers. RHEUMATOLOGY, 55(9), 1556-1565. doi:10.1093/rheumatology/kev429

DOI: 10.1093/rheumatology/kev429

INVESTIGATING THE NEUTROPHIL-MACROPHAGE INTERPLAY IN JUVENILE LUPUS NEPHRITIS PATHOGENESIS (Conference Paper)

Dimou, P., Midgley, A., Peak, M., Wright, R. D., & Beresford, M. W. (2016). INVESTIGATING THE NEUTROPHIL-MACROPHAGE INTERPLAY IN JUVENILE LUPUS NEPHRITIS PATHOGENESIS. In ANNALS OF THE RHEUMATIC DISEASES Vol. 75 (pp. 914-915). doi:10.1136/annrheumdis-2016-eular.5116

DOI: 10.1136/annrheumdis-2016-eular.5116

INVESTIGATING THE PHAGOCYTIC POTENTIAL OF NEUTROPHILS FROM JUVENILE-ONSET SYSTEMIC LUPUS ERYTHEMATOSUS (JSLE) PATIENTS (Conference Paper)

Glaser, A. E. A., Wright, H. L., Midgley, A., Peak, M., & Beresford, M. W. (2016). INVESTIGATING THE PHAGOCYTIC POTENTIAL OF NEUTROPHILS FROM JUVENILE-ONSET SYSTEMIC LUPUS ERYTHEMATOSUS (JSLE) PATIENTS. In ANNALS OF THE RHEUMATIC DISEASES Vol. 75 (pp. 941). doi:10.1136/annrheumdis-2016-eular.5342

DOI: 10.1136/annrheumdis-2016-eular.5342

Increased concentration of plasma TNFR1 and TNFR2 in paediatric lupus nephritis (Journal article)

Patel, M., Oni, L., Midgley, A., Smith, E., Tullus, K., Marks, S. D., . . . Beresford, M. W. (2016). Increased concentration of plasma TNFR1 and TNFR2 in paediatric lupus nephritis. LUPUS, 25(9), 1040-1044. doi:10.1177/0961203316631634

DOI: 10.1177/0961203316631634

Increased expression of low density granulocytes in juvenile-onset systemic lupus erythematosus patients correlates with disease activity (Journal article)

Midgley, A., & Beresford, M. W. (2016). Increased expression of low density granulocytes in juvenile-onset systemic lupus erythematosus patients correlates with disease activity. LUPUS, 25(4), 407-411. doi:10.1177/0961203315608959

DOI: 10.1177/0961203315608959

JUVENILE-ONSET LUPUS NEPHRITIS: INVESTIGATING THE ROLE OF THE GLOMERULAR ENDOTHELIAL CELLS IN NOVEL URINE BIOMARKER PRODUCTION (Conference Paper)

Dimou, P., Midgley, A., Peak, M., Satchell, S. C., Wright, R. D., & Beresford, M. W. (2016). JUVENILE-ONSET LUPUS NEPHRITIS: INVESTIGATING THE ROLE OF THE GLOMERULAR ENDOTHELIAL CELLS IN NOVEL URINE BIOMARKER PRODUCTION. In CLINICAL AND EXPERIMENTAL RHEUMATOLOGY Vol. 34 (pp. S88). Retrieved from http://gateway.webofknowledge.com/

Pharmacological Management of Childhood-Onset Systemic Lupus Erythematosus (Journal article)

Thorbinson, C., Oni, L., Smith, E., Midgley, A., & Beresford, M. W. (2016). Pharmacological Management of Childhood-Onset Systemic Lupus Erythematosus. PEDIATRIC DRUGS, 18(3), 181-195. doi:10.1007/s40272-016-0170-8

DOI: 10.1007/s40272-016-0170-8

Population pharmacokinetics and pharmacodynamics of teicoplanin in neonates: making better use of C-reactive protein to deliver individualized therapy (Journal article)

Ramos-Martin, V., Neely, M. N., McGowan, P., Siner, S., Padmore, K., Peak, M., . . . Hope, W. W. (2016). Population pharmacokinetics and pharmacodynamics of teicoplanin in neonates: making better use of C-reactive protein to deliver individualized therapy. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 71(11), 3168-3178. doi:10.1093/jac/dkw295

DOI: 10.1093/jac/dkw295

ROLE OF THE PODOCYTES IN BIOMARKER PRODUCTION IN JUVENILE LUPUS NEPHRITIS (Conference Paper)

Wright, R., & Beresford, M. W. (2016). ROLE OF THE PODOCYTES IN BIOMARKER PRODUCTION IN JUVENILE LUPUS NEPHRITIS. In CLINICAL AND EXPERIMENTAL RHEUMATOLOGY Vol. 34 (pp. S72). Retrieved from http://gateway.webofknowledge.com/

SHARE RECOMMENDATIONS ON CONNECTIVE TISSUE DISEASES (Conference Paper)

Beresford, M. W. (2016). SHARE RECOMMENDATIONS ON CONNECTIVE TISSUE DISEASES. In ANNALS OF THE RHEUMATIC DISEASES Vol. 75 (pp. 16). doi:10.1136/annrheumdis-2016-eular.6387

DOI: 10.1136/annrheumdis-2016-eular.6387

STUDYING THE POTENTIAL OF NEUTROPHILS FROM JUVENILE-ONSET SYSTEMIC LUPUS ERYTHEMATOSUS (JSLE) PATIENTS FOR PHAGOCYTOSIS (Conference Paper)

Glaser, A., Wright, H. L., Wright, R. D., Midgley, A., Peak, M., & Beresford, M. W. (2016). STUDYING THE POTENTIAL OF NEUTROPHILS FROM JUVENILE-ONSET SYSTEMIC LUPUS ERYTHEMATOSUS (JSLE) PATIENTS FOR PHAGOCYTOSIS. In CLINICAL AND EXPERIMENTAL RHEUMATOLOGY Vol. 34 (pp. S57). Retrieved from http://gateway.webofknowledge.com/

Urinary biomarkers in childhood lupus nephritis. (Journal article)

Smith, E. M. D., & Beresford, M. W. (2016). Urinary biomarkers in childhood lupus nephritis.. Clinical immunology (Orlando, Fla.). doi:10.1016/j.clim.2016.06.010

DOI: 10.1016/j.clim.2016.06.010

2015

AN EXCELLENT BIOMARKER PANEL FOR IDENTIFICATION OF ACTIVE LUPUS NEPHRITIS IN CHILDREN (Conference Paper)

Smith, E. M. D. D., Oni, L., Midgley, A., Tullus, K., Pilkington, C., Marks, S., . . . Beresford, M. W. (2015). AN EXCELLENT BIOMARKER PANEL FOR IDENTIFICATION OF ACTIVE LUPUS NEPHRITIS IN CHILDREN. In NEPHROLOGY DIALYSIS TRANSPLANTATION Vol. 30. doi:10.1093/ndt/gfv153.5

DOI: 10.1093/ndt/gfv153.5

Characterization of Human Disease Phenotypes Associated with Mutations in TREX1, RNASEH2A, RNASEH2B, RNASEH2C, SAMHD1, ADAR, and IFIH1 (Journal article)

Crow, Y. J., Chase, D. S., Schmidt, J. L., Szynkiewicz, M., Forte, G. M. A., Gornall, H. L., . . . Rice, G. I. (2015). Characterization of Human Disease Phenotypes Associated with Mutations in TREX1, RNASEH2A, RNASEH2B, RNASEH2C, SAMHD1, ADAR, and IFIH1. AMERICAN JOURNAL OF MEDICAL GENETICS PART A, 167(2), 296-312. doi:10.1002/ajmg.a.36887

DOI: 10.1002/ajmg.a.36887

Co-existence of juvenile-onset systemic lupus erythematosus and juvenile myasthenia gravis (Journal article)

Sampath, S., McCann, L. J., McDonagh, J., Cleary, G., Spinty, S., Pain, C. E., . . . Beresford, M. W. (2015). Co-existence of juvenile-onset systemic lupus erythematosus and juvenile myasthenia gravis. LUPUS, 24(13), 1462-1463. doi:10.1177/0961203315591030

DOI: 10.1177/0961203315591030

DEMONSTRATION OF AN "EXCELLENT" BIOMARKER PANEL FOR IDENTIFYING ACTIVE LUPUS NEPHRITIS IN CHILDREN (Conference Paper)

Smith, E., Oni, L., Midgley, A., Ekdawy, D., Corkhill, R., Jones, C., . . . Beresford, M. W. (2015). DEMONSTRATION OF AN "EXCELLENT" BIOMARKER PANEL FOR IDENTIFYING ACTIVE LUPUS NEPHRITIS IN CHILDREN. In ANNALS OF THE RHEUMATIC DISEASES Vol. 74 (pp. 331). doi:10.1136/annrheumdis-2015-eular.3352

DOI: 10.1136/annrheumdis-2015-eular.3352

DEVELOPING A URINARY BIOMARKER PANEL FOR MONITORING LUPUS NEPHRITIS DISEASE ACTIVITY (Conference Paper)

Smith, E. M. D., Corkhill, R., Midgley, A., Watson, L., Jones, C., Marks, S. D., . . . Beresford, M. W. (2015). DEVELOPING A URINARY BIOMARKER PANEL FOR MONITORING LUPUS NEPHRITIS DISEASE ACTIVITY. In RHEUMATOLOGY Vol. 54 (pp. 3). doi:10.1093/rheumatology/keu492

DOI: 10.1093/rheumatology/keu492

DEVELOPMENT OF AN INTERNATIONALLY AGREED MINIMAL DATASET FOR JUVENILE DERMATOMYOSITIS (JDM) FOR CLINICAL AND RESEARCH USE (Conference Paper)

McCann, L., Wedderburn, L. R., Pilkington, C., Huber, A. M., Ravelli, A., Williamson, P., . . . Beresford, M. W. (2015). DEVELOPMENT OF AN INTERNATIONALLY AGREED MINIMAL DATASET FOR JUVENILE DERMATOMYOSITIS (JDM) FOR CLINICAL AND RESEARCH USE. In ANNALS OF THE RHEUMATIC DISEASES Vol. 74 (pp. 837-838). doi:10.1136/annrheumdis-2015-eular.2479

DOI: 10.1136/annrheumdis-2015-eular.2479

Development of an Internationally Agreed Minimal Dataset for Juvenile Dermatomyositis (JDM) for Clinical and Research Use (Journal article)

McCann, L. J., Wedderburn, L. R., Pilkington, C., Huber, A. M., Ravelli, A., Kirkham, J., . . . Beresford, M. W. (2015). Development of an Internationally Agreed Minimal Dataset for Juvenile Dermatomyositis (JDM) for Clinical and Research Use. ARTHRITIS & RHEUMATOLOGY, 67. Retrieved from http://gateway.webofknowledge.com/

Development of an internationally agreed minimal dataset for juvenile dermatomyositis (JDM) for clinical and research use (Journal article)

McCann, L. J., Kirkham, J. J., Wedderburn, L. R., Pilkington, C., Huber, A. M., Ravelli, A., . . . Beresford, M. W. (2015). Development of an internationally agreed minimal dataset for juvenile dermatomyositis (JDM) for clinical and research use. TRIALS, 16. doi:10.1186/s13063-015-0784-0

DOI: 10.1186/s13063-015-0784-0

Differential changes in gene expression in human neutrophils following TNF-α stimulation: Up-regulation of anti-apoptotic proteins and down-regulation of proteins involved in death receptor signaling. (Journal article)

Chiewchengchol, D., Wright, H. L., Thomas, H. B., Lam, C. W., Roberts, K. J., Hirankarn, N., . . . Edwards, S. W. (2016). Differential changes in gene expression in human neutrophils following TNF-α stimulation: Up-regulation of anti-apoptotic proteins and down-regulation of proteins involved in death receptor signaling.. Immunity, Inflammation and Disease, 4(1), 35-44. doi:10.1002/iid3.90

DOI: 10.1002/iid3.90

EFFECTS OF INTERFERON ALPHA ON NEUTROPHIL APOPTOSIS AND CASPASE 3 CLEAVAGE (Conference Paper)

Irwin, S., Midgley, A., & Beresford, M. W. (2015). EFFECTS OF INTERFERON ALPHA ON NEUTROPHIL APOPTOSIS AND CASPASE 3 CLEAVAGE. In ANNALS OF THE RHEUMATIC DISEASES Vol. 74 (pp. 915). doi:10.1136/annrheumdis-2015-eular.3415

DOI: 10.1136/annrheumdis-2015-eular.3415

Elicitation of Expert Prior Opinion: Application to the MYPAN Trial in Childhood Polyarteritis Nodosa (Journal article)

Hampson, L. V., Whitehead, J., Eleftheriou, D., Tudur-Smith, C., Jones, R., Jayne, D., . . . Brogan, P. A. (2015). Elicitation of Expert Prior Opinion: Application to the MYPAN Trial in Childhood Polyarteritis Nodosa. PLOS ONE, 10(3). doi:10.1371/journal.pone.0120981

DOI: 10.1371/journal.pone.0120981

FACTORS ASSOCIATED WITH CHOICE OF FIRST BIOLOGIC AMONG CHILDREN WITH JIA: A COMBINED ANALYSIS FROM TWO UK PAEDIATRIC BIOLOGIC REGISTERS (Conference Paper)

Kearsley-Fleet, L., Davies, R., Baildam, E., Beresford, M. W., Foster, H. E., Southwood, T. R., . . . Adolescent, B. S. P. (2015). FACTORS ASSOCIATED WITH CHOICE OF FIRST BIOLOGIC AMONG CHILDREN WITH JIA: A COMBINED ANALYSIS FROM TWO UK PAEDIATRIC BIOLOGIC REGISTERS. In RHEUMATOLOGY Vol. 54 (pp. 5). doi:10.1093/rheumatology/keu494

DOI: 10.1093/rheumatology/keu494

FELTY'S SYNDROME IN RHEUMATOID FACTOR POSITIVE POLYARTICULAR JUVENILE IDIOPATHIC ARTHRITIS: THE ROLE OF RITUXIMAB (Conference Paper)

Brown, L. E., Sampath, S., Ryan, F., Pain, C. E., McCann, L. J., Cleary, G., . . . Baildam, E. M. (2015). FELTY'S SYNDROME IN RHEUMATOID FACTOR POSITIVE POLYARTICULAR JUVENILE IDIOPATHIC ARTHRITIS: THE ROLE OF RITUXIMAB. In RHEUMATOLOGY Vol. 54 (pp. 7). doi:10.1093/rheumatology/keu499

DOI: 10.1093/rheumatology/keu499

INHIBITION OF IFN ALPHA SIGNALLING REDUCES HMGB1 TRANSLOCATION AND NEUTROPHIL EXTRACELLULAR TRAP FORMATION IN JUVENILE-ONSET SYSTEMIC LUPUS ERYTHEMATOSUS (JSLE) (Conference Paper)

Midgley, A., & Beresford, M. W. (2015). INHIBITION OF IFN ALPHA SIGNALLING REDUCES HMGB1 TRANSLOCATION AND NEUTROPHIL EXTRACELLULAR TRAP FORMATION IN JUVENILE-ONSET SYSTEMIC LUPUS ERYTHEMATOSUS (JSLE). In ANNALS OF THE RHEUMATIC DISEASES Vol. 74 (pp. 204-205). doi:10.1136/annrheumdis-2015-eular.5537

DOI: 10.1136/annrheumdis-2015-eular.5537

Increased soluble phagocytic receptors sMer, sTyro3 and sAxl and reduced phagocytosis in Juvenile-onset Systemic Lupus Erythematosus (Journal article)

Ballantine, L., Midgley, A., Harris, D., Richards, E., Burgess, S., & Beresford, M. W. (2015). Increased soluble phagocytic receptors sMer, sTyro3 and sAxl and reduced phagocytosis in Juvenile-onset Systemic Lupus Erythematosus. PEDIATRIC RHEUMATOLOGY, 13. doi:10.1186/s12969-015-0007-y

DOI: 10.1186/s12969-015-0007-y

Inter-observer variability of the histological classification of lupus glomerulonephritis in children (Journal article)

Oni, L., Beresford, M. W., Witte, D., Chatzitolios, A., Sebire, N., Abulaban, K., . . . Brunner, H. I. (2017). Inter-observer variability of the histological classification of lupus glomerulonephritis in children. LUPUS, 26(11), 1205-1211. doi:10.1177/0961203317706558

DOI: 10.1177/0961203317706558

Juvenile-onset systemic lupus erythematosus: how to diagnose and manage (Journal article)

Oni, L., Thorbinson, C., & Beresford, M. W. (2015). Juvenile-onset systemic lupus erythematosus: how to diagnose and manage. Paediatrics and Child Health, 25(12), 555-560. doi:10.1016/j.paed.2015.07.005

DOI: 10.1016/j.paed.2015.07.005

Methotrexate polyglutamates as a potential marker of adherence to long-term therapy in children with juvenile idiopathic arthritis and juvenile dermatomyositis: an observational, cross-sectional study (Journal article)

Hawwa, A. F., AlBawab, A., Rooney, M., Wedderburn, L. R., Beresford, M. W., & McElnay, J. C. (2015). Methotrexate polyglutamates as a potential marker of adherence to long-term therapy in children with juvenile idiopathic arthritis and juvenile dermatomyositis: an observational, cross-sectional study. ARTHRITIS RESEARCH & THERAPY, 17. doi:10.1186/s13075-015-0814-z

DOI: 10.1186/s13075-015-0814-z

Mucocutaneous manifestations in juvenile-onset systemic lupus erythematosus: a review of literature (Journal article)

Chiewchengchol, D., Murphy, R., Edwards, S. W., & Beresford, M. W. (2015). Mucocutaneous manifestations in juvenile-onset systemic lupus erythematosus: a review of literature. PEDIATRIC RHEUMATOLOGY, 13. doi:10.1186/1546-0096-13-1

DOI: 10.1186/1546-0096-13-1

NGS Panel for the Detection of Monogenic SLE in Children: Initial Results (Journal article)

Belot, A., Rice, G., Mathieu, A. -L., Bader-Meunier, B., Walzer, T., Briggs, T. A., . . . Grp, U. K. J. S. L. E. S. (2015). NGS Panel for the Detection of Monogenic SLE in Children: Initial Results. ARTHRITIS & RHEUMATOLOGY, 67. Retrieved from http://gateway.webofknowledge.com/

RESPONSE TO RITUXIMAB IN PATIENTS WITH REFRACTORY SYSTEMIC LUPUS ERYTHEMATOSUS (SLE): RESULTS FROM A NATIONAL MULTI-CENTRE REGISTER (Conference Paper)

Sutton, E. J., Watson, K. D., Isenberg, D. A., Rahman, A., Jayne, D., Gordon, C., . . . Bruce, I. N. (2015). RESPONSE TO RITUXIMAB IN PATIENTS WITH REFRACTORY SYSTEMIC LUPUS ERYTHEMATOSUS (SLE): RESULTS FROM A NATIONAL MULTI-CENTRE REGISTER. In RHEUMATOLOGY Vol. 54 (pp. 30-31). Retrieved from http://gateway.webofknowledge.com/

THE RENAL STATUS OF THE UK JUVENILE-SLE COHORT (Conference Paper)

Oni, L., Richards, E., Smith, E., & Beresford, M. W. (2015). THE RENAL STATUS OF THE UK JUVENILE-SLE COHORT. In NEPHROLOGY DIALYSIS TRANSPLANTATION Vol. 30. doi:10.1093/ndt/gfv203.2

DOI: 10.1093/ndt/gfv203.2

The development and assessment of biological treatments for children (Journal article)

Smith, E. M. D., Foster, H. E., & Beresford, M. W. (2015). The development and assessment of biological treatments for children. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 79(3), 379-394. doi:10.1111/bcp.12406

DOI: 10.1111/bcp.12406

The indications, efficacy and adverse events of rituximab in a large cohort of patients with juvenile-onset SLE (Journal article)

Watson, L., Beresford, M. W., Maynes, C., Pilkington, C., Marks, S. D., Glackin, Y., & Tullus, K. (2015). The indications, efficacy and adverse events of rituximab in a large cohort of patients with juvenile-onset SLE. LUPUS, 24(1), 10-17. doi:10.1177/0961203314547793

DOI: 10.1177/0961203314547793

The protective effect of GM-CSF on serum-induced neutrophil apoptosis in juvenile systemic lupus erythematosus patients (Journal article)

Chiewchengchol, D., Midgley, A., Sodsai, P., Deekajorndech, T., Hirankarn, N., Beresford, M. W., & Edwards, S. W. (2015). The protective effect of GM-CSF on serum-induced neutrophil apoptosis in juvenile systemic lupus erythematosus patients. CLINICAL RHEUMATOLOGY, 34(1), 85-91. doi:10.1007/s10067-014-2800-2

DOI: 10.1007/s10067-014-2800-2

2014

A COMPARISON OF THE AMERICAN COLLEGE OF RHEUMATOLOGY AND THE SYSTEMIC LUPUS INTERNATIONAL COLLABORATING CLINICS CLASSIFICATION CRITERIA (Conference Paper)

Lloyd, O., Heaf, E., Morgan, T., Roberts, C., McCann, L., Beresford, M. W., & Grp, U. K. J. S. L. E. S. (2014). A COMPARISON OF THE AMERICAN COLLEGE OF RHEUMATOLOGY AND THE SYSTEMIC LUPUS INTERNATIONAL COLLABORATING CLINICS CLASSIFICATION CRITERIA. In RHEUMATOLOGY Vol. 53 (pp. 13). Retrieved from http://gateway.webofknowledge.com/

A Novel Dried Blood Spot-LCMS Method for the Quantification of Methotrexate Polyglutamates as a Potential Marker for Methotrexate Use in Children (Journal article)

Hawwa, A. F., AlBawab, A., Rooney, M., Wedderburn, L. R., Beresford, M. W., & McElnay, J. C. (2014). A Novel Dried Blood Spot-LCMS Method for the Quantification of Methotrexate Polyglutamates as a Potential Marker for Methotrexate Use in Children. PLOS ONE, 9(2). doi:10.1371/journal.pone.0089908

DOI: 10.1371/journal.pone.0089908

A Randomised Controlled Trial of the Clinical Effectiveness, Safety and Cost-Effectiveness of Adalimumab in Combination with Methotrexate for the Treatment of Juvenile Idiopathic Arthritis Associated Uveitis (Journal article)

Ramanan, A. V., Dick, A. D., McKay, A., Jones, A., Williamson, P., Compeyrot-Lacassagne, S., . . . Beresford, M. W. (2015). A Randomised Controlled Trial of the Clinical Effectiveness, Safety and Cost-Effectiveness of Adalimumab in Combination with Methotrexate for the Treatment of Juvenile Idiopathic Arthritis Associated Uveitis. ARTHRITIS & RHEUMATOLOGY, 67. Retrieved from http://gateway.webofknowledge.com/

A SYSTEMATIC LITERATURE REVIEW ON DIAGNOSIS AND TREATMENT OF PAEDIATRIC RHEUMATIC DISEASES: A SHARED INITIATIVE (Conference Paper)

Groot, N., Boom, V., de Graeff, N., Enders, F. B., ter Haar, N., Sperotto, F., . . . Consortium, S. H. A. R. E. (2014). A SYSTEMATIC LITERATURE REVIEW ON DIAGNOSIS AND TREATMENT OF PAEDIATRIC RHEUMATIC DISEASES: A SHARED INITIATIVE. In RHEUMATOLOGY Vol. 53 (pp. 13). Retrieved from http://gateway.webofknowledge.com/

A SYSTEMATIC LITERATURE REVIEW ON DIAGNOSIS AND TREATMENT OF PAEDIATRIC RHEUMATIC DISEASES: A SHARED INITIATIVE (Conference Paper)

Groot, N., Boom, V., de Graeff, N., Enders, F. B., ter Haar, N., Sperotto, F., . . . Consortium, S. H. A. R. E. (2014). A SYSTEMATIC LITERATURE REVIEW ON DIAGNOSIS AND TREATMENT OF PAEDIATRIC RHEUMATIC DISEASES: A SHARED INITIATIVE. In RHEUMATOLOGY Vol. 53 (pp. 22). Retrieved from http://gateway.webofknowledge.com/

A randomised controlled trial of the clinical effectiveness, safety and cost-effectiveness of adalimumab in combination with methotrexate for the treatment of juvenile idiopathic arthritis associated uveitis (SYCAMORE Trial) (Journal article)

Ramanan, A. V., Dick, A. D., Benton, D., Compeyrot-Lacassagne, S., Dawoud, D., Hardwick, B., . . . Grp, S. Y. C. A. M. O. R. E. T. M. (2014). A randomised controlled trial of the clinical effectiveness, safety and cost-effectiveness of adalimumab in combination with methotrexate for the treatment of juvenile idiopathic arthritis associated uveitis (SYCAMORE Trial). TRIALS, 15. doi:10.1186/1745-6215-15-14

DOI: 10.1186/1745-6215-15-14

BIOLOGIC CHOICES AFTER FIRST-LINE ANTI-TUMOUR NECROSIS FACTOR FAILURE IN NON-SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS (Conference Paper)

Richards, H., Baildam, E., McCann, L. J., Cleary, A. G., Beresford, M. W., & Pain, C. E. (2014). BIOLOGIC CHOICES AFTER FIRST-LINE ANTI-TUMOUR NECROSIS FACTOR FAILURE IN NON-SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS. In RHEUMATOLOGY Vol. 53 (pp. 8). Retrieved from http://gateway.webofknowledge.com/

Connective tissue diseases in children (Chapter)

Wedderburn, L. R., Pilkington, C. A., & Beresford, M. W. (2014). Connective tissue diseases in children. In Rheumatology: Sixth Edition (Vol. 1-2, pp. 868-875). doi:10.1016/B978-0-323-09138-1.00105-4

DOI: 10.1016/B978-0-323-09138-1.00105-4

Developing a provisional, international Minimal Dataset for Juvenile Dermatomyositis: for use in clinical practice to inform research (Journal article)

McCann, L. J., Arnold, K., Pilkington, C. A., Huber, A. M., Ravelli, A., Beard, L., . . . Gr, U. K. J. D. R. (2014). Developing a provisional, international Minimal Dataset for Juvenile Dermatomyositis: for use in clinical practice to inform research. PEDIATRIC RHEUMATOLOGY, 12. doi:10.1186/1546-0096-12-31

DOI: 10.1186/1546-0096-12-31

Factors Associated with Choice of First Biologic Among Children with Juvenile Idiopathic Arthritis: A Combined Analysis from 2 UK Paediatric Biologic Registers. (Journal article)

Davies, R., Kearsley-Fleet, L., Baildam, E., Beresford, M. W., Foster, H. E., Southwood, T. R., . . . Biol, C. R. D. B. C. R. D. S. (2014). Factors Associated with Choice of First Biologic Among Children with Juvenile Idiopathic Arthritis: A Combined Analysis from 2 UK Paediatric Biologic Registers.. ARTHRITIS & RHEUMATOLOGY, 66, S114-S115. Retrieved from http://gateway.webofknowledge.com/

Gain-of-function mutations in IFIH1 cause a spectrum of human disease phenotypes associated with upregulated type I interferon signaling (Journal article)

Rice, G. I., Duany, Y. D. T., Jenkinson, E. M., Forte, G. M. A., Anderson, B. H., Ariaudo, G., . . . Grow, Y. J. (2014). Gain-of-function mutations in IFIH1 cause a spectrum of human disease phenotypes associated with upregulated type I interferon signaling. NATURE GENETICS, 46(5), 503-509. doi:10.1038/ng.2933

DOI: 10.1038/ng.2933

IMPROVING CARE IN PAEDIATRIC RHEUMATIC DISEASES: THE SHARE PROJECT (Conference Paper)

Groot, N., Vastert, B., Wulffraat, N. M., Beresford, M. W., & Consortium, S. H. A. R. E. (2014). IMPROVING CARE IN PAEDIATRIC RHEUMATIC DISEASES: THE SHARE PROJECT. In RHEUMATOLOGY Vol. 53 (pp. 22). Retrieved from http://gateway.webofknowledge.com/

IMPROVING CARE IN PAEDIATRIC RHEUMATOLOGIC DISEASES: THE SHARE PROJECT (Conference Paper)

Groot, N., Vastert, B., Wulffraat, N. M., Beresford, M. W., & Consortium, S. H. A. R. E. (2014). IMPROVING CARE IN PAEDIATRIC RHEUMATOLOGIC DISEASES: THE SHARE PROJECT. In RHEUMATOLOGY Vol. 53 (pp. 12-13). Retrieved from http://gateway.webofknowledge.com/

INVESTIGATING BIOMARKERS OF DISEASE ACTIVITY IN JUVENILE-ONSET LUPUS NEPHRITIS (Conference Paper)

Smith, E. M. D., Watson, L., Jones, C., Pilkington, C. A., Marks, S. D., Tullus, K., & Beresford, M. W. (2014). INVESTIGATING BIOMARKERS OF DISEASE ACTIVITY IN JUVENILE-ONSET LUPUS NEPHRITIS. In RHEUMATOLOGY Vol. 53 (pp. 21). Retrieved from http://gateway.webofknowledge.com/

INVESTIGATING PHAGOCYTOSIS RECEPTORS IN SERUM FROM JUVENILE-ONSET SYSTEMIC LUPUS ERYTHREMATOSUS PATIENTS (Conference Paper)

Burgess, S. L., Ballantine, L., Midgley, A., & Beresford, M. W. (2014). INVESTIGATING PHAGOCYTOSIS RECEPTORS IN SERUM FROM JUVENILE-ONSET SYSTEMIC LUPUS ERYTHREMATOSUS PATIENTS. In RHEUMATOLOGY Vol. 53 (pp. 21). Retrieved from http://gateway.webofknowledge.com/

Methodology of clinical trials for rare diseases (Journal article)

Smith, C. T., Williamson, P. R., & Beresford, M. W. (2014). Methodology of clinical trials for rare diseases. BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY, 28(2), 247-262. doi:10.1016/j.berh.2014.03.004

DOI: 10.1016/j.berh.2014.03.004

Methodology of clinical trials for rare diseases (Journal article)

Tudur Smith, C., Williamson, P. R., & Beresford, M. W. (2014). Methodology of clinical trials for rare diseases. Best Practice and Research: Clinical Rheumatology, 28(2), 247-262. doi:10.1016/j.berh.2014.03.0045

DOI: 10.1016/j.berh.2014.03.0045

Mucocutaneous manifestations in a UK national cohort of juvenile-onset systemic lupus erythematosus patients (Journal article)

Chiewchengchol, D., Murphy, R., Morgan, T., Edwards, S. W., Leone, V., Friswell, M., . . . Grp, U. K. J. S. L. E. S. (2014). Mucocutaneous manifestations in a UK national cohort of juvenile-onset systemic lupus erythematosus patients. RHEUMATOLOGY, 53(8), 1504-1512. doi:10.1093/rheumatology/keu137

DOI: 10.1093/rheumatology/keu137

New insights into the pathogenesis and management of lupus in children (Journal article)

Midgley, A., Watson, L., & Beresford, M. W. (2014). New insights into the pathogenesis and management of lupus in children. ARCHIVES OF DISEASE IN CHILDHOOD, 99(6), 563-567. doi:10.1136/archdischild-2013-304397

DOI: 10.1136/archdischild-2013-304397

Population Pharmacokinetics of Teicoplanin in Children (Journal article)

Ramos-Martin, V., Paulus, S., Siner, S., Scott, E., Padmore, K., Newland, P., . . . Hope, W. W. (2014). Population Pharmacokinetics of Teicoplanin in Children. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 58(11), 6920-6927. doi:10.1128/AAC.03685-14

DOI: 10.1128/AAC.03685-14

Predictors of access to care in juvenile systemic lupus erythematosus: evidence from the UK JSLE Cohort Study (Journal article)

Smith, E. M. D., Foster, H. E., Gray, W. K., Taylor-Robinson, D., Beresford, M. W., & Grp, U. K. J. S. L. E. S. (2014). Predictors of access to care in juvenile systemic lupus erythematosus: evidence from the UK JSLE Cohort Study. RHEUMATOLOGY, 53(3), 557-561. doi:10.1093/rheumatology/ket402

DOI: 10.1093/rheumatology/ket402

RELATIVE EXPRESSION OF KIDNEY-ASSOCIATED PROTEINS IN LUPUS NEPHRITIS: IDENTIFYING FUTURE URINARY BIOMARKER TARGETS FOR DISEASE MONITORING (Conference Paper)

Smith, E. M. D., Midgley, A., Watson, L., Jones, C., Pilkington, C., Marks, S. D., . . . Beresford, M. W. (2014). RELATIVE EXPRESSION OF KIDNEY-ASSOCIATED PROTEINS IN LUPUS NEPHRITIS: IDENTIFYING FUTURE URINARY BIOMARKER TARGETS FOR DISEASE MONITORING. In RHEUMATOLOGY Vol. 53 (pp. 183-184). Retrieved from http://gateway.webofknowledge.com/

Response to Rituximab in Patients with Refractory Systemic Lupus Erythematosus (SLE): Results from a National Multicentre Register (Journal article)

Sutton, E., Watson, K. D., Isenberg, D. A., Rahman, A., Jayne, D., Gordon, C., . . . Bruce, I. N. (2014). Response to Rituximab in Patients with Refractory Systemic Lupus Erythematosus (SLE): Results from a National Multicentre Register. ARTHRITIS & RHEUMATOLOGY, 66, S295. Retrieved from http://gateway.webofknowledge.com/

THE EFFICACY OF RITUXIMAB IN JUVENILE-ONSET SLE: A RETROSPECTIVE COHORT STUDY (Conference Paper)

Watson, L., Maynes, C., Pilkington, C., Marks, S., Beresford, M. W., & Tullus, K. (2014). THE EFFICACY OF RITUXIMAB IN JUVENILE-ONSET SLE: A RETROSPECTIVE COHORT STUDY. In RHEUMATOLOGY Vol. 53 (pp. 14). Retrieved from http://gateway.webofknowledge.com/

THE PREVALENCE AND INTERPRETATION OF ANTIPHOSPHOLIPID ANTIBODIES IN JUVENILE SYSTEMIC LUPUS ERYTHEMATOSUS (Conference Paper)

Saleem, M. S., Simpson, D. L., Roberts, C. J., Ramanan, A. V., Beresford, M. W., & Grp, U. K. J. S. L. E. S. (2014). THE PREVALENCE AND INTERPRETATION OF ANTIPHOSPHOLIPID ANTIBODIES IN JUVENILE SYSTEMIC LUPUS ERYTHEMATOSUS. In RHEUMATOLOGY Vol. 53 (pp. 20). Retrieved from http://gateway.webofknowledge.com/

TWO CASES OF JUVENILE SYSTEMIC LUPUS ERYTHEMATOSUS WITH UNCOMMON ASSOCIATIONS AND CHALLENGES IN THERAPY (Conference Paper)

Sampath, S., Cleary, A. G., Pain, C. E., Baildam, E., Beresford, M. W., & McCann, L. J. (2014). TWO CASES OF JUVENILE SYSTEMIC LUPUS ERYTHEMATOSUS WITH UNCOMMON ASSOCIATIONS AND CHALLENGES IN THERAPY. In RHEUMATOLOGY Vol. 53 (pp. 11). Retrieved from http://gateway.webofknowledge.com/

The pro-inflammatory potential of T cells in juvenile-onset systemic lupus erythematosus (Journal article)

Ballantine, L. E., Ong, J., Midgley, A., Watson, L., Flanagan, B. F., & Beresford, M. W. (2014). The pro-inflammatory potential of T cells in juvenile-onset systemic lupus erythematosus. PEDIATRIC RHEUMATOLOGY, 12. doi:10.1186/1546-0096-12-4

DOI: 10.1186/1546-0096-12-4

USE OF RITUXIMAB IN RHEUMATOID FACTOR NEGATIVE JUVENILE RHEUMATOID ARTHRITIS (Conference Paper)

Sampath, S., Baildam, E., Cleary, A. G., Pain, C. E., Beresford, M. W., & McCann, L. J. (2014). USE OF RITUXIMAB IN RHEUMATOID FACTOR NEGATIVE JUVENILE RHEUMATOID ARTHRITIS. In RHEUMATOLOGY Vol. 53 (pp. 11). Retrieved from http://gateway.webofknowledge.com/

Urine biomarkers for monitoring juvenile lupus nephritis: a prospective longitudinal study (Journal article)

Watson, L., Tullus, K., Pilkington, C., Chesters, C., Marks, S. D., Newland, P., . . . Beresford, M. W. (2014). Urine biomarkers for monitoring juvenile lupus nephritis: a prospective longitudinal study. PEDIATRIC NEPHROLOGY, 29(3), 397-405. doi:10.1007/s00467-013-2668-4

DOI: 10.1007/s00467-013-2668-4

2013

Children and adolescents with SLE: not just little adults. (Journal article)

Morgan, T., Watson, L., McCann, L., & Beresford, M. (2013). Children and adolescents with SLE: not just little adults.. Lupus, 22(12), 1309-1319.

Urine biomarkers in juvenile-onset SLE nephritis. (Journal article)

Watson, L., & Beresford, M. (2013). Urine biomarkers in juvenile-onset SLE nephritis.. Pediatric Nephrology, 28(3), 363-374.

2012

Adding to complexity: comorbidity in paediatric rheumatic disease (Journal article)

Smith, E. M. D., Foster, H. E., & Beresford, M. W. (2013). Adding to complexity: comorbidity in paediatric rheumatic disease. Rheumatology, 52(1), 22-33. doi:10.1093/rheumatology/kes256

DOI: 10.1093/rheumatology/kes256

Disease activity, severity, and damage in the UK Juvenile-Onset Systemic Lupus Erythematosus Cohort. (Journal article)

Watson, L., Leone, V., Pilkington, C., Tullus, K., Rangaraj, S., McDonagh, J. E., . . . Beresford, M. (2012). Disease activity, severity, and damage in the UK Juvenile-Onset Systemic Lupus Erythematosus Cohort.. Arthritis and Rheumatism, 64(7), 2356-2365.

Disease activity, severity, and damage in the UK juvenile-onset systemic lupus erythematosus cohort (Journal article)

Watson, L., Leone, V., Pilkington, C., Tullus, K., Rangaraj, S., McDonagh, J. E., . . . Beresford, M. W. (2012). Disease activity, severity, and damage in the UK juvenile-onset systemic lupus erythematosus cohort. Arthritis & Rheumatism, 64(7), 2356-2365. doi:10.1002/art.34410

DOI: 10.1002/art.34410

Expression of Toll-like receptors and their detection of nuclear self-antigen leading to immune activation in JSLE (Journal article)

Midgley, A., Thorbinson, C., & Beresford, M. W. (2012). Expression of Toll-like receptors and their detection of nuclear self-antigen leading to immune activation in JSLE. Rheumatology, 51(5), 824-832. doi:10.1093/rheumatology/ker400

DOI: 10.1093/rheumatology/ker400

Expression of Toll-like receptors and their detection of nuclear self-antigen leading to immune activation in JSLE. (Journal article)

Midgley, A., Thorbinson, C., & Beresford, M. W. (2012). Expression of Toll-like receptors and their detection of nuclear self-antigen leading to immune activation in JSLE.. Rheumatology, 51(5), 824-832.

Henoch schonlein purpura - a 5-year review and proposed pathway (Journal article)

Watson, L., Richardson, A. R. W., Holt, R. C. L., Jones, C. A., & Beresford, M. W. (2012). Henoch schonlein purpura - a 5-year review and proposed pathway. PLoS One, 7(1), e29512. Epub 2012 Jan 3.

Henoch schonlein purpura--a 5-year review and proposed pathway (Journal article)

Watson, L., Richardson, A. R. W., Holt, R. C. L., Jones, C. A., & Beresford, M. (2012). Henoch schonlein purpura--a 5-year review and proposed pathway. PloS one, 7(1).

Inactive Disease and Remission in Childhood-onset Systemic Lupus Erythematosus. (Journal article)

Mina, R., Ravelli, A., Klein-Gitelman, M. S., Avcin, T., Espada, G., Eberhard, B. A., . . . Beresford, M. (2012). Inactive Disease and Remission in Childhood-onset Systemic Lupus Erythematosus.. Arthritis Care & Research (Hoboken), 64(5), 683-693.

Increased serum concentration of sphingosine-1-phosphate in juvenile-onset systemic lupus erythematosus (Journal article)

Watson, L., Tullus, K., Marks, S. D., Holt, R. C. L., Pilkington, C., & Beresford, M. W. (2012). Increased serum concentration of sphingosine-1-phosphate in juvenile-onset systemic lupus erythematosus. J Clin Immunol, 32(5), 1019-1025.

Increased serum concentration of sphingosine-1-phosphate in juvenile-onset systemic lupus erythematosus. (Journal article)

Watson, L., Tullus, K., Marks, S. D., Holt, R. C. L., Pilkington, C., & Beresford, M. (2012). Increased serum concentration of sphingosine-1-phosphate in juvenile-onset systemic lupus erythematosus.. Journal of Clinical Immunology, 32(5), 1019-1025.

Juvenile idiopathic arthritis: Symptoms and diagnosis. (Journal article)

Kelly, J., & Beresford, M. W. (2012). Juvenile idiopathic arthritis: Symptoms and diagnosis.. British Journal of School Nursing, 7(3), 117-120.

Paediatric use of mycophenolate mofetil (Journal article)

Downing, H. J., Pirmohamed, M., Beresford, M. W., & Smyth, R. L. (2013). Paediatric use of mycophenolate mofetil. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 75(1), 45-59. doi:10.1111/j.1365-2125.2012.04305.x

DOI: 10.1111/j.1365-2125.2012.04305.x

Standards for child health trial design, conduct and reporting: Standard 5: Selection, measurement and reporting of outcomes (Journal article)

Sinha, I. P., Altman, D., Beresford, M. W., Boers, M., Clarke, M., Craig, J., . . . Smyth, R. L. (2012). Standards for child health trial design, conduct and reporting: Standard 5: Selection, measurement and reporting of outcomes. Pediatrics, 129(Suppl), 146-152.

Urinary Monocyte Chemoattractant protein 1 and Alpha-1-acid glycoprotein as biomarkers of renal disease activity in Juvenile-onset Systemic Lupus Erythematosus (Journal article)

Watson, L., Midgley, A., Pilkington, C., Tullus, K., Holt, R. L., Marks, S., . . . Beresford, M. W. (2012). Urinary Monocyte Chemoattractant protein 1 and Alpha-1-acid glycoprotein as biomarkers of renal disease activity in Juvenile-onset Systemic Lupus Erythematosus. Lupus, 21, 496-501.

Urinary monocyte chemoattractant protein 1 and alpha 1 acid glycoprotein as biomarkers of renal disease activity in juvenile-onset systemic lupus erythematosus. (Journal article)

Watson, L., Midgley, A., Pilkington, C., Tullus, K., Marks, S. D., Holt, R. C. L., . . . Beresford, M. (2012). Urinary monocyte chemoattractant protein 1 and alpha 1 acid glycoprotein as biomarkers of renal disease activity in juvenile-onset systemic lupus erythematosus.. Lupus, 21(5), 496-501.

Urine biomarkers in Juvenile-onset SLE nephritis (Journal article)

Watson, L., & Beresford, M. W. (2012). Urine biomarkers in Juvenile-onset SLE nephritis. Journal of Paediatric Nephrology.

2011

Cellular localisation of nuclear antigen during neutrophil apoptosis: Mechanism for auto-antigen exposure? (Journal article)

Midgley, A. M., & Beresford, M. W. (2011). Cellular localisation of nuclear antigen during neutrophil apoptosis: Mechanism for auto-antigen exposure?. Lupus, 20, 641.

Communication about children's clinical trials as observed and experienced: qualitative study of parents and practitioners (Journal article)

Shilling, V., Williamson, P. R., Hickey, H., Sowden, E., Beresford, M. W., Smyth, R. L., & Young, B. (2011). Communication about children's clinical trials as observed and experienced: qualitative study of parents and practitioners. PLoS One, 6(7), e21604.

Diagnosis and management of juvenile-onset SLE (Journal article)

Watson, L., Gohar, F., & Beresford, M. W. (2011). Diagnosis and management of juvenile-onset SLE. Pediatrics and Child Health, 21(12), 539-545.

Differential expression of factors involved in the intrinsic and extrinsic apoptotic pathways in Juvenile Systemic Lupus Erythematosus: The role of caspases. (Journal article)

Midgley, A. M., Mayer, K., Edwards, S. W., & Beresford, M. W. (2011). Differential expression of factors involved in the intrinsic and extrinsic apoptotic pathways in Juvenile Systemic Lupus Erythematosus: The role of caspases.. Lupus, 20(1), 71.

International consensus for a definition of disease flare in lupus. (Journal article)

Ruperto, N., Hanrahan, L. M., Alarcón, G. S., Belmont, H. M., Brey, R. L., Brunetta, P., . . . al., E. (2011). International consensus for a definition of disease flare in lupus.. Lupus, 13(3), 453-462.

Juvenile Idiopathic Arthritis: New Insights into Classification, Measures of Outcome and pharmacotherapy (Journal article)

Beresford, M. W. (2011). Juvenile Idiopathic Arthritis: New Insights into Classification, Measures of Outcome and pharmacotherapy. Pediatric Drugs, 13(3), 161.

Needle-free and microneedle drug delivery in children: A case for disease-modifying antirheumatic drugs (DMARDs) (Journal article)

Shah, U. U., Roberts, M., Gul, M. O., Tuleu., Beresford, M. W., & the MCRN/Arthritis Research UK Paediatric Rheumatology Clinical, O. B. O. (2011). Needle-free and microneedle drug delivery in children: A case for disease-modifying antirheumatic drugs (DMARDs). Int J Pharm, 416(1), 1-11.

Paediatric Connective Tissue Disorders (Chapter)

Wedderburn, L. R., Pilkington, C. A., & Beresford, M. W. (2011). Paediatric Connective Tissue Disorders. In M. Hochberg, A. J. Silman, J. S. Smolen, M. E. Weinblatt, & M. H. Weisman (Eds.), Rheumatology, 5th Edition (pp. 1035-1043). PA, USA: Elsevier,.

Preliminary Criteria for Global Flares in Childhood-Onset Systemic Lupus Erythematosu (Journal article)

Brunner, H. I., Mina, R., Pilkington, C., Beresford, M. W., Reiff, A., Levy, D., . . . Giannini, E. (2011). Preliminary Criteria for Global Flares in Childhood-Onset Systemic Lupus Erythematosu. Arthritis Care Res (Hoboken), 63(9), 1213-1223.

Tartrate-resistant acid phosphatase deficiency causes a bone dysplasia with autoimmunity and a type I interferon expression signature (Journal article)

Briggs, T. A., Rice, G. I., Daly, S., Urquhart, J., Gornall, H., Bader-Meunier, B., . . . Crow, Y. J. (2011). Tartrate-resistant acid phosphatase deficiency causes a bone dysplasia with autoimmunity and a type I interferon expression signature. Nature Genetics, 43(2), 127-131. doi:10.1038/ng.748

DOI: 10.1038/ng.748

2010

A randomized comparative trial of generalized vs targeted physiotherapy in the management of childhood hypermobility (Journal article)

Kemp, S., Roberts, I., Gamble, C., Wilkinson, S., Davidson, J. E., Baildam, E. M., . . . Beresford, M. W. (2010). A randomized comparative trial of generalized vs targeted physiotherapy in the management of childhood hypermobility. Rheumatology, 49(2), 315-325. doi:10.1093/rheumatology/kep362

DOI: 10.1093/rheumatology/kep362

A retrospective clinical analysis of pharmacological modalities used for symptomatic relief of Raynaud's phenomenon in children treated in a UK paediatric rheumatology centre (Journal article)

Gargh, K., Baildam, E. M., Cleary, G. A., Beresford, M. W., & McCann, L. J. (2010). A retrospective clinical analysis of pharmacological modalities used for symptomatic relief of Raynaud's phenomenon in children treated in a UK paediatric rheumatology centre. Rheumatology, 49(1), 193-194. doi:10.1093/rheumatology/kep309

DOI: 10.1093/rheumatology/kep309

Comment on: Developing standards of care for patients with juvenile idiopathic arthritis. (Journal article)

Beresford, M., Cleary, A. G., Foster, H. E., Hutchinson, E., Baildam, E. M., & Davies, K. (2010). Comment on: Developing standards of care for patients with juvenile idiopathic arthritis.. Rheumatology, 49(11), 2227-2229.

Disease modifying immunosuppressant drugs for juvenile-onset systemic lupus erythematosus. Cochrane Database of Systematic Reviews (Journal article)

Craig, J. V., Pain, C. E., & Beresford, M. W. (2010). Disease modifying immunosuppressant drugs for juvenile-onset systemic lupus erythematosus. Cochrane Database of Systematic Reviews. Cochrane Database of Systematic Reviews, Issue.

2009

"To find the right answers, you need to ask the right questions." Consumer involvement in setting our research agenda (Journal article)

Hill, H., Kelly, J., Kemp, S., Baildam, E., Cleary, A. G., McCann, L., & Beresford, M. W. (2009). "To find the right answers, you need to ask the right questions." Consumer involvement in setting our research agenda. Rheumatology, Pendin, Pending.

Decreased expression of proteins that inhibit apoptosis in patients with JSLE compared to controls. (Journal article)

Midgley, A. J., & Beresford, M. W. (2009). Decreased expression of proteins that inhibit apoptosis in patients with JSLE compared to controls.. Rheumatology (accepted for BSR 2009), Pendin, Pending.

Delay to diagnosis in juvenile SLE (JSLE) patients: preliminary data from the UK JSLE Cohort Study (Journal article)

Pain, C., Gardner-Medwin, J., McDonagh, J., Pilkington, C., Satyapal, R., Tizard, J., . . . Beresford, M. W. (2009). Delay to diagnosis in juvenile SLE (JSLE) patients: preliminary data from the UK JSLE Cohort Study. Rheumatology, Suppl(48), i46(56).

Increased CD80 and CD86 in the serum of patients with JSLE compared to controls (Journal article)

Midgley, A., & Beresford, M. W. (2009). Increased CD80 and CD86 in the serum of patients with JSLE compared to controls. Rheumatology (accepted for BSR 2009), Pendin, Pending.

New advances in the management of juvenile idiopathic arthritis--1: Non-biological therapy (Journal article)

Beresford, M. W., & Baildam, E. M. (2009). New advances in the management of juvenile idiopathic arthritis--1: Non-biological therapy. Archives of Disease in Childhood - Education and Practice, 94(5), 144-150. doi:10.1136/adc.2008.144576

DOI: 10.1136/adc.2008.144576

New advances in the management of juvenile idiopathic arthritis--2: The era of biologicals (Journal article)

Beresford, M. W., & Baildam, E. M. (2009). New advances in the management of juvenile idiopathic arthritis--2: The era of biologicals. Archives of Disease in Childhood - Education and Practice, 94(5), 151-156. doi:10.1136/adc.2009.170860

DOI: 10.1136/adc.2009.170860

The role of neutrophil apoptosis in juvenile-onset systemic lupus erythematosus (Journal article)

Midgley, A., McLaren, Z., Moots, R. J., Edwards, S. W., & Beresford, M. W. (2009). The role of neutrophil apoptosis in juvenile-onset systemic lupus erythematosus. Arthritis & Rheumatism, 60(8), 2390-2401. doi:10.1002/art.24634

DOI: 10.1002/art.24634

2008

A new new paradigm for musculoskeletal clinical trials in the UK: the Arthritis Research Campaign (arc) Clinical Studies Groups Initiative (Journal article)

Silman, A. (2008). A new new paradigm for musculoskeletal clinical trials in the UK: the Arthritis Research Campaign (arc) Clinical Studies Groups Initiative. Rheumatology.

Arthropathy in children with inflammatory bowel disease: a cross-sectional observational study (Journal article)

McErlane, F., Gillon, C., Irvine, T., Davidson, J. E., Casson, D., Dalzell, M., & Beresford, M. W. (2008). Arthropathy in children with inflammatory bowel disease: a cross-sectional observational study. Rheumatology.

Costing juvenile idiopathic arthritis: examining patient-based costs during the first year after diagnosis (Journal article)

Thornton, J., Lunt, M., Ashcroft, D. M., Baildam, E., Foster, H., Davidson, J., . . . Elliott, R. A. (2008). Costing juvenile idiopathic arthritis: examining patient-based costs during the first year after diagnosis. Rheumatology, Advanced publication 160408.

Improving the evidence base for treatment of juvenile idiopathic arthritis: the challenge and opportunity facing the MCRN/ARC Paediatric Rheumatology Clinical Studies Group (Journal article)

Thornton, J., Beresford, M. W., & Clayton, P. (2008). Improving the evidence base for treatment of juvenile idiopathic arthritis: the challenge and opportunity facing the MCRN/ARC Paediatric Rheumatology Clinical Studies Group. Rheumatology, 47(5), 563-566. doi:10.1093/rheumatology/ken055

DOI: 10.1093/rheumatology/ken055

Increased neutrophil apoptosis may be associated with decreased levels of IL-6, GM-CSF and TNF-alpha concentrations in JSLE serum compared to controls (Journal article)

Midgley, A. J., McLaren, Z., Moots, R. J., Edwards, S. E., & Beresford, M. W. (2008). Increased neutrophil apoptosis may be associated with decreased levels of IL-6, GM-CSF and TNF-alpha concentrations in JSLE serum compared to controls. 3rd International Conference on Cytokine Medicine., *(*), *.

Inducing apoptosis: Increased TRAIL and FasL concentrations in JSLE serum compared to controls (Journal article)

Midgley, A. J., McLaren, Z. L., Moots, R. J., Edwards, S. W., & Beresford, M. W. (2008). Inducing apoptosis: Increased TRAIL and FasL concentrations in JSLE serum compared to controls. Lupus, 17(5), suppl:495.

Modulation of the immune inhibitory pathway: Increased expression of TLR's in JSLE lymphocytes correlates with decreased FoxP3 expression (Journal article)

Midgley, A. J., & Beresford, M. W. (2008). Modulation of the immune inhibitory pathway: Increased expression of TLR's in JSLE lymphocytes correlates with decreased FoxP3 expression. Immunology, 125, (suppl 1):OP173.

Peripheral T-cell lymphoma in a five year old (Journal article)

Beresford, M. W., Wilkins, S., Ashworth, M., Davidson, J. E., McDowell, H., & Cleary, A. G. (2008). Peripheral T-cell lymphoma in a five year old. Pediatric Blood & Cancer, 50(1), 145-147. doi:10.1002/pbc.21055

DOI: 10.1002/pbc.21055

Role of Neutrophil Apoptosis in Juvenile-onset SLE (Journal article)

McLaren, Z. L., Midgley, A. J., Moots, R. J., Edwards, S. W., & Beresford, M. W. (2008). Role of Neutrophil Apoptosis in Juvenile-onset SLE. Rheumatology, 47, (suppl 2):ii94(320).

Steroid use in the management of acute juvenile systemic lupus erythematosus - A National Survey (Journal article)

McLaren, Z. L., Beresford, M. W., & on, B. O. U. J. S. G. (2008). Steroid use in the management of acute juvenile systemic lupus erythematosus - A National Survey. Rheumatology, 47, (suppl 2):ii27(89).

The Role of Neutrophil Apoptosis in Juvenile-onset Systemic Lupus Erythematosus (Journal article)

Midgley, A., McLaren, Z., Moots, R. J., Edwards, S. W., & Beresford, M. W. (2008). The Role of Neutrophil Apoptosis in Juvenile-onset Systemic Lupus Erythematosus. ACR Pediatric Rheumatology Symposium, Keystone 2008, Awaite, Abstract 124.

The addition of granulocyte macrophage colony stimulating factor (GM-CSF) to Juvenile systemic lupus erythematusos serum can reduce abnormal neutrophil apoptosis (Journal article)

Midgley, A. J., McLaren, Z. L., Moots, R. J., Edwards, S. W., & Beresford, M. W. (2008). The addition of granulocyte macrophage colony stimulating factor (GM-CSF) to Juvenile systemic lupus erythematusos serum can reduce abnormal neutrophil apoptosis. Pediatric Rheumatology, 6(Supp, P232.

UK Paediatric rheumatology clinical trials network (Journal article)

Beresford, M., Balidam, E. M., Brogan, P. A., Foster, H. E., Ramanan, A. V., Rooney, M. E., . . . Woo, P. (2008). UK Paediatric rheumatology clinical trials network. Pediatric Rheumatology, 6(Supp, P150.

2007

Acrimonious acronyms: CRMO, SAPHO and a sore shin (Journal article)

Beresford, M. W., Deautschmann, A., & Sullivan, K. E. (2007). Acrimonious acronyms: CRMO, SAPHO and a sore shin. Clinical Immunology, 122(3), 252-254. doi:10.1016/j.clim.2006.11.006

DOI: 10.1016/j.clim.2006.11.006

Costing juvenile idiopathic arthritis: examining patient-based costs during the first year after diagnosis (Journal article)

Thornton, J., Lunt, M., Ashcroft, D., Baildam, E., Foster, H., Davidson, J., . . . Elliott, R. (2007). Costing juvenile idiopathic arthritis: examining patient-based costs during the first year after diagnosis. Rheumatology.

Development of a national multi-centre, multi-disciplinary collaborative registry & repository of patients with juvenile-onset SLE (Journal article)

Beresford, M. W. (2007). Development of a national multi-centre, multi-disciplinary collaborative registry & repository of patients with juvenile-onset SLE. Lupus, 16 (su, 49.

ETFDH mutations as a major cause of riboflavin-responsive multiple acyl-CoA dehydrogenation deficiency (Journal article)

Olsen, R. K. J., Olpin, S. E., Andresen, B. S., Miedzybrodzka, Z. H., Pourfarzam, M., Merinero, B., . . . Morris, A. A. M. (2007). ETFDH mutations as a major cause of riboflavin-responsive multiple acyl-CoA dehydrogenation deficiency. Brain, 130(8), 2045-2054. doi:10.1093/brain/awm135

DOI: 10.1093/brain/awm135

Juvenile-onset Lupus (Chapter)

Beresford, M. W. (2007). Juvenile-onset Lupus. In Y. Norton (Ed.), Lupus: GP Guide to Diagnosis (pp. Awaited). London: Lupus UK.

Neonatal Lupus Syndrome (Journal article)

Pain, C., & Beresford, M. W. (2007). Neonatal Lupus Syndrome. Paediatrics and Child Health, 17(6), 223-227.

2006

Acute life threatening events among infants on home oxygen (Journal article)

Harrison, G., Beresford, M. W., & Shaw, N. (2006). Acute life threatening events among infants on home oxygen. Paediatric Nursing, 18(2), 27-29.

Adolescent development and SLE (Journal article)

Beresford, M. W., & Davidson, J. E. (2006). Adolescent development and SLE. Best Practice & Research Clinical Rheumatology, 20(2), 353-368. doi:10.1016/j.berh.2005.11.003

DOI: 10.1016/j.berh.2005.11.003

So doctor, what exactly is wrong with my muscles? Glutaric aciduria type II presenting in a teenager (Journal article)

Beresford, M. W., Pourfarzam, M., Turnbull, D. M., & Davidson, J. E. (2006). So doctor, what exactly is wrong with my muscles? Glutaric aciduria type II presenting in a teenager. Neuromuscular Disorders, 16(4), 269-273. doi:10.1016/j.nmd.2006.01.001

DOI: 10.1016/j.nmd.2006.01.001

“So doctor, what exactly is wrong with my muscles? Glutaric aciduria type II presenting in a teenager” (Journal article)

Beresford, M. W., Pourfarzam, M., & Davidson, J. E. (2006). “So doctor, what exactly is wrong with my muscles? Glutaric aciduria type II presenting in a teenager”. Neuromuscular Disorders, 16(9-10), 613. doi:10.1016/j.nmd.2006.07.003

DOI: 10.1016/j.nmd.2006.07.003

2005

Arthropathy in children with inflammatory bowel disease: a cross-sectional observational study (Journal article)

Erlane, F., Gillon, C., Irvine, T., Beresford, M. W., & Davidson, J. (2005). Arthropathy in children with inflammatory bowel disease: a cross-sectional observational study. Arch Dis Child, 90 (s2, A52.

Cardiopulmonary involvement in juvenile systemic lupus erythematosus (Journal article)

Beresford, M. W., Cleary, A. G., Sills, J. A., Couriel, J., & Davidson, J. E. (2005). Cardiopulmonary involvement in juvenile systemic lupus erythematosus. Lupus, 14(1), 152-158.

Clinical presentation and subsequent manifestations of juvenile-onset SLE in the UK (Journal article)

Beresford, M. W., Hernandez, T., McDonagh, J., Ryder, C. A. J., & Davidson, J. E. (2005). Clinical presentation and subsequent manifestations of juvenile-onset SLE in the UK. Lupus, 14, 259.

Delayed diagnosis: JIA in children with learning difficulties (Journal article)

Beresford, M. W., Cleary, A. G., Sills, J. A., & Davidson, J. E. (2005). Delayed diagnosis: JIA in children with learning difficulties. Rheumatology, 44 (su, i121.

Does sustained lung inflation at resuscitation reduce lung injury in the preterm infant? (Journal article)

Harling, A. E. (2005). Does sustained lung inflation at resuscitation reduce lung injury in the preterm infant?. Archives of Disease in Childhood - Fetal and Neonatal Edition, 90(5), F406-F410. doi:10.1136/adc.2004.059303

DOI: 10.1136/adc.2004.059303

Does the use of 50% oxygen at birth in preterm infants reduce lung injury? (Journal article)

Harling, A. E. (2005). Does the use of 50% oxygen at birth in preterm infants reduce lung injury?. Archives of Disease in Childhood - Fetal and Neonatal Edition, 90(5), F401-F405. doi:10.1136/adc.2004.059287

DOI: 10.1136/adc.2004.059287

Evaluation of a limping child (Journal article)

Beresford, M. W., & Cleary, A. G. (2005). Evaluation of a limping child. Current Paediatrics, 15, 15-22.

Paediatric blood monitoring on methotrexate: How often are results abnormal? (Journal article)

Kelly, J., Cleary, A. G., Davidson, J. E., Sills, J., & Beresford, M. W. (2005). Paediatric blood monitoring on methotrexate: How often are results abnormal?. Clin Exp Rheumatol, 23 sup, S75.

Peripheral T-cell lymphoma: Important differential diagnosis of panniculitis in 5 year old (Journal article)

Beresford, M. W., Ashworth, M., McErlane, F., Davidson, J. E., & Cleary, A. G. (2005). Peripheral T-cell lymphoma: Important differential diagnosis of panniculitis in 5 year old. Clin Exp Rheumatol, 23 sup, S76.

Twelve month prospective study of oxygen saturation measurements among term and preterm infants (Journal article)

Beresford, M. W., Parry, H., & Shaw, N. J. (2005). Twelve month prospective study of oxygen saturation measurements among term and preterm infants. J Perinatol, 25, 30-32.

2004

Association of glutathione-S-transferase-P1 (GSTP1) polymorphism 105 Ile>val with chronic lung disease in preterm infants. (Journal article)

Cooke, R. W., Drury, J. A., Beresford, M. W., & Shaw, N. J. (2004). Association of glutathione-S-transferase-P1 (GSTP1) polymorphism 105 Ile>val with chronic lung disease in preterm infants.. Journal of perinatology : official journal of the California Perinatal Association, 24(12), 800. doi:10.1038/sj.jp.7211145

DOI: 10.1038/sj.jp.7211145

Pamidronate in the treatment of childhood SAPHO syndrome (Journal article)

Kerrison, C. (2004). Pamidronate in the treatment of childhood SAPHO syndrome. Rheumatology, 43(10), 1246-1251. doi:10.1093/rheumatology/keh295

DOI: 10.1093/rheumatology/keh295

2003

Bronchoalveolar Lavage Surfactant Protein A, B, and D Concentrations in Preterm Infants Ventilated for Respiratory Distress Syndrome Receiving Natural and Synthetic Surfactants (Journal article)

Beresford, M. W., & Shaw, N. J. (2003). Bronchoalveolar Lavage Surfactant Protein A, B, and D Concentrations in Preterm Infants Ventilated for Respiratory Distress Syndrome Receiving Natural and Synthetic Surfactants. Pediatric Research, 53(4), 663-670. doi:10.1203/01.PDR.0000054653.89527.F8

DOI: 10.1203/01.PDR.0000054653.89527.F8

2002

Detectable interleukin 8 and 10 in BAL fluid from preterm infants ventilated for RDS (Journal article)

Beresford, M. W., & Shaw, N. J. (2002). Detectable interleukin 8 and 10 in BAL fluid from preterm infants ventilated for RDS. Pediatr Res, 52(6), 973-978. doi:10.1203/00006450-200212000-00025

DOI: 10.1203/00006450-200212000-00025

Randomised, double blind, placebo controlled trail of inhaled fluticasone for chronic lung disease of prematurity. (Journal article)

Beresford, M. W., Primak, R., Subhedar, N. S., & Shaw, N. J. (2002). Randomised, double blind, placebo controlled trail of inhaled fluticasone for chronic lung disease of prematurity.. Arch Dis Child Fetal Neonatal Ed, 87(1), F62-F63.

2000

A Review of Outcome of Babies with Congenital Diaphragmatic Hernia (Journal article)

Beresford, M. W., & Shaw, N. J. (2000). A Review of Outcome of Babies with Congenital Diaphragmatic Hernia. Pediatr Pulmonol, 30(3), 249-256.

Poractant alfa and pumactant for treatment of respiratory distress syndrome in neonates born at 25 to 29 weeks¿ gestation: a randomised trial (Journal article)

Ainsworth, S., Beresford, M. W., Milligan, D. W. A., Shaw, N. J., Matthews, J. N. S., Fenton, A. C., & Ward Platt, M. P. (2000). Poractant alfa and pumactant for treatment of respiratory distress syndrome in neonates born at 25 to 29 weeks¿ gestation: a randomised trial. Lancet, 355(9213), 1387-1392.

Pumactant and poractant alfa in respiratory distress syndrome. Correspondence (Journal article)

Ainsworth, S., Beresford, M. W., Milligan, D. W. A., Shaw, N. J., & Matthews, J. N. S. (2000). Pumactant and poractant alfa in respiratory distress syndrome. Correspondence. Lancet, 356, 765-766.

Randomised controlled trial of patient triggered and conventional fast rate ventilation in neonatal respiratory distress syndrome (Journal article)

Beresford, M. W., Shaw, N. J., & Manning, D. (2000). Randomised controlled trial of patient triggered and conventional fast rate ventilation in neonatal respiratory distress syndrome. Arch Dis Child Fetal & Neonatal Ed, 82(1), F14-F18.

Respiratory syncytial virus infection in high risk infants and the potential impact of prophylaxis in a United Kingdom cohort (Journal article)

Clark, S. J. (2000). Respiratory syncytial virus infection in high risk infants and the potential impact of prophylaxis in a United Kingdom cohort. Archives of Disease in Childhood, 83(4), 313-316. doi:10.1136/adc.83.4.313

DOI: 10.1136/adc.83.4.313

Undated

Investigating phagocytic markers in Juvenile-onset Systemic Lupus Erythematosus (JSLE) monocytes and macrophages (Thesis / Dissertation)

Harris, D. (n.d.). Investigating phagocytic markers in Juvenile-onset Systemic Lupus Erythematosus (JSLE) monocytes and macrophages. (Master's Thesis, University of Liverpool).

Investigating the IL-17 family and Th17-related cytokines in juvenile-onset systemic lupus erythematosus (Thesis / Dissertation)

Ong, J. S. H. (n.d.). Investigating the IL-17 family and Th17-related cytokines in juvenile-onset systemic lupus erythematosus. (Master's Thesis, University of Liverpool).

Investigating the role of Toll-like receptors in juvenile onset systemic lupus erythematosus (Thesis / Dissertation)

Thorbinson, C. (n.d.). Investigating the role of Toll-like receptors in juvenile onset systemic lupus erythematosus. (Master's Thesis, University of Liverpool).

Neutrophil function in juvenile systemic Lupus Erythematosus (JSLE) (Thesis / Dissertation)

Chiewchengchol, D. (n.d.). Neutrophil function in juvenile systemic Lupus Erythematosus (JSLE). (PhD Thesis, University of Liverpool).

Renal biomarkers in Juvenile-onset systemic lupus erythematosus (Thesis / Dissertation)

Watson, L. (n.d.). Renal biomarkers in Juvenile-onset systemic lupus erythematosus. (PhD Thesis, University of Liverpool).